Polycore Therapeutics Secures Seed Financing To Address Motor Symptoms And Dyskinesia Associated With Parkinson’s Disease
Round Type
Seed
PhiladelphiaBiotechnologyDescription
PolyCore Therapeutics, Inc., a biopharmaceutical company developing treatments for patients suffering from dyskinesia and cognitive impairment associated with neurodegenerative disorders, today announced a seed investment from Xontogeny, LLC and Ben Franklin Technology Partners of Southeastern Pennsylvania to advance their lead compound, PCT-3012, a novel G protein-biased D3 receptor agonist to reduce motor impairment in Parkinson’s Disease, through IND-enabling work.
Quick answer
PolyCore Therapeutics, Inc. raised an undisclosed amount in a Seed round, dated April 11, 2022. PolyCore Therapeutics, Inc. is based in Philadelphia, Pennsylvania, United States.
- How much did PolyCore Therapeutics, Inc. raise?
- PolyCore Therapeutics, Inc. raised an undisclosed amount in a Seed round on April 11, 2022.
- Where is PolyCore Therapeutics, Inc. based and how big is it?
- PolyCore Therapeutics, Inc. is based in Philadelphia, Pennsylvania, United States.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as PolyCore Therapeutics, Inc. that raised within 45 days of this round, from Fundz verified event records.
- SpinaFX raised $6.9M (Series A) on May 26, 2022.
- Mazen Animal Health Inc. raised $11M on May 26, 2022.
- Full Life Technologies raised $37M (Series A) on May 26, 2022.
- Neuvivo raised an undisclosed amount (Funding Round) on May 26, 2022.
- Aurora Cannabis raised $125M (Funding Round) on May 26, 2022.
- CARI Health raised $800K on May 26, 2022.
Who to call at PolyCore Therapeutics, Inc., and when
A new round usually means PolyCore Therapeutics, Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day PolyCore Therapeutics, Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at PolyCore Therapeutics, Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at PolyCore Therapeutics, Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment PolyCore Therapeutics, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
PolyCore Therapeutics, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.